A detailed history of Silvant Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Silvant Capital Management LLC holds 1,411 shares of GILD stock, worth $124,280. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,411
Previous 1,411 -0.0%
Holding current value
$124,280
Previous $96,000 22.92%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$57.92 - $72.58 $1.42 Million - $1.78 Million
-24,463 Reduced 94.55%
1,411 $84,000
Q4 2021

Feb 07, 2022

SELL
$64.88 - $73.64 $94,724 - $107,514
-1,460 Reduced 5.34%
25,874 $1.88 Million
Q3 2021

Nov 08, 2021

SELL
$67.69 - $73.03 $167,329 - $180,530
-2,472 Reduced 8.29%
27,334 $1.91 Million
Q2 2021

Aug 03, 2021

SELL
$63.47 - $69.35 $42,651 - $46,603
-672 Reduced 2.2%
29,806 $2.05 Million
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $8,384 - $9,553
-148 Reduced 0.48%
30,478 $1.78 Million
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $33,285 - $41,850
-536 Reduced 1.72%
30,626 $1.94 Million
Q4 2019

Feb 10, 2020

SELL
$61.62 - $67.78 $10,352 - $11,387
-168 Reduced 0.54%
31,162 $2.03 Million
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $18,065 - $19,941
-289 Reduced 0.91%
31,330 $1.99 Million
Q2 2019

Aug 09, 2019

SELL
$61.87 - $69.38 $15,962 - $17,900
-258 Reduced 0.81%
31,619 $2.14 Million
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $11,255 - $12,609
-180 Reduced 0.56%
31,877 $2.07 Million
Q4 2018

Feb 06, 2019

SELL
$60.54 - $79.0 $2.21 Million - $2.88 Million
-36,438 Reduced 53.2%
32,057 $2.01 Million
Q3 2018

Nov 07, 2018

SELL
$71.28 - $78.92 $33,216 - $36,776
-466 Reduced 0.68%
68,495 $5.29 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $55,861 - $65,160
861 Added 1.26%
68,961 $4.89 Million
Q1 2018

May 09, 2018

BUY
$72.84 - $88.8 $4.96 Million - $6.05 Million
68,100 New
68,100 $5.13 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.